<DOC>
	<DOCNO>NCT01489488</DOCNO>
	<brief_summary>Primary objective : To determine oral bioavailability liquid formulation intend pediatric use potential food effect healthy adult . Secondary objective : To evaluate safety tolerability measure physical examination finding , vital sign , electrocardiogram ( ECG ) , laboratory parameter , adverse event ( AEs ) .</brief_summary>
	<brief_title>Relative Bioavailability Food Effect Study</brief_title>
	<detailed_description>Clinical pharmacology</detailed_description>
	<criteria>Healthy male female volunteer Age 1845 year Body mass index ( BMI ) 18.029.9 kg/mÂ² Systolic blood pressure ( SBP ) 110145 mmHg No drug 2 week treatment Nonsmokers least 12 week Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal Medical disorder would impair subject 's ability complete study opinion Investigator Known hypersensitivity study drug ( active substance excipients preparation ) Known severe allergy , nonallergic drug reaction , multiple drug allergy Relevant diseases within last 4 week prior first study drug administration Regular use medicine Regular use therapeutic recreational drug Use medication within 2 week precede study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Relative bioavailability study</keyword>
</DOC>